stage III prostate cancer
Showing 9976 - 10000 of >10,000
Rectal Tumors Malignant, Rectum Carcinoma, Rectal Cancer Trial in Moscow (drug, radiation, procedure)
Enrolling by invitation
- Rectal Neoplasms Malignant
- +2 more
- Capecitabine
- +3 more
-
Moscow, Russian FederationN.N.Blokhin Russian Cancer Research Center
Feb 7, 2021
Neuroimaging and End Stage Renal Disease
Recruiting
- End Stage Renal Disease
- magnetic resonance image (MRI)
-
Xian, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Apr 26, 2022
Pancreas Cancer, Pancreas Tumor, Pancreas Adenocarcinoma Trial (Laparoscopic surgical biopsy and organoid generation)
Not yet recruiting
- Pancreas Cancer
- +5 more
- Laparoscopic surgical biopsy and organoid generation
- (no location specified)
Apr 22, 2022
The Gastric Cancer Foundation: A Gastric Cancer Registry
Recruiting
- Gastric Cancer
-
Stanford, CaliforniaStanford University, School of Medicine
Oct 24, 2022
Whole Body Magnetic Resonance Imaging Study
Active, not recruiting
- Advanced Prostate Cancer
- WB-MRI
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
May 18, 2021
Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer Trial (BI 765049, Ezabenlimab)
Not yet recruiting
- Gastrointestinal Cancer
- +5 more
- BI 765049
- Ezabenlimab
- (no location specified)
Oct 16, 2023
Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)
Recruiting
- Gastric Cancer
- sintilimab+metronomic PLOF
-
Shanghai, ChinaHuashan Hospital, Fudan University
Sep 22, 2023
Functional Gastrointestinal Disorders Trial in Stockholm (Patient education program)
Completed
- Functional Gastrointestinal Disorders
- Patient education program
-
Stockholm, SwedenKarolinka Institutet
Dec 16, 2021
Breast Cancer Patients Trial (Yoga Exercises)
Active, not recruiting
- Breast Cancer Patients
- Yoga Exercises
- (no location specified)
Aug 16, 2021
End Stage Renal Disease Trial in Washington (Drotrecogin alfa activated (Xigris))
Completed
- End Stage Renal Disease
- Drotrecogin alfa activated (Xigris)
-
Washington, District of ColumbiaThe George Washington University Hospital
Jan 6, 2022
Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)
Not yet recruiting
- Mycosis Fungoides
- Cutaneous T Cell Lymphoma
- Low-dose total-skin electron-beam therapy
- Phototherapy
- (no location specified)
Jan 24, 2022
Quality of Life, Breast Cancer Trial in France (ADA, Usual Care)
Not yet recruiting
- Quality of Life
- Breast Cancer
- ADA
- Usual Care
-
Marseille, Bouches DU RHON, France
- +9 more
Dec 16, 2022
Achieving Equity in Genomic Testing for Breast Cancer Through
Recruiting
- Breast Cancer
-
Stanford, CaliforniaStanford University School of Medicine
Jun 14, 2023
Stage I Uterine Sarcoma AJCC v7, Uterine Corpus Leiomyosarcoma Trial in Worldwide (other, drug, biological)
Terminated
- Stage I Uterine Sarcoma AJCC v7
- Uterine Corpus Leiomyosarcoma
- Clinical Observation
- +5 more
-
Huntsville, Alabama
- +622 more
Apr 20, 2020
Colorectal Cancer Screening in Cystic Fibrosis
Recruiting
- Cystic Fibrosis
- +2 more
- Stool tests
-
Los Angeles, California
- +24 more
Jan 26, 2023
Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,
Not yet recruiting
- Breast Cancer
- Chemotherapy Effect
- Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
- Epirubicin, Cyclophosphamide, Docetaxel
- (no location specified)
Jun 21, 2023
Oxycodone Trial (Oxycodone 1mg/kg, Oxycodone 1.5mg/kg, Sufentanil)
Not yet recruiting
- Oxycodone
- Oxycodone 1mg/kg
- +2 more
- (no location specified)
Feb 15, 2023
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Scottsdale (Counseling, Discussion, Informational
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Counseling
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Gynecologic Cancer, Chemo Effect, Chemo-brain Trial (Cognitive training application)
Not yet recruiting
- Gynecologic Cancer
- +3 more
- Cognitive training application
- (no location specified)
May 8, 2023
Breast Cancer Trial in Amsterdam (Intensified Cyclophophamide, Carboplatin and Thiotepa, dose dense adriamycine and
Terminated
- Breast Cancer
- Intensified Cyclophophamide, Carboplatin and Thiotepa
- dose dense adriamycine and cyclophosphamide
-
Amsterdam, NetherlandsNKI-AVL
Jan 20, 2021
(PMS) for the Long-term Safety of VAXZEVRIA
Active, not recruiting
- Prevention of Infectious Disease Caused by SARS-CoV-2
-
Chiba, Japan
- +5 more
Nov 24, 2022
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021